Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Hunt

Showing results (281-290 of 342) with videos related to

Pageof 35
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
A Distinct Form of Subcutaneous Fat Fibrosis Predicts Insulin Resistance in People with HIVDiana L Alba, Moon K Choi, Alaa Abdellatif, et al.
The Journal of Infectious Diseases|September 9, 2015
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral TherapyMark J Siedner, June-Ho Kim, Ruth Sentongo Nakku, et al.
Blood|April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialPeter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
Cannabis and Cannabinoid Research|March 26, 2026
Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIVStephanie A Ruderman, Joseph A C Delaney, Kristina A Crothers, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
AIDS (London, England)|February 26, 2021
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in UgandaSuzanne M McCluskey, Kimia Kamelian, Nicholas Musinguzi, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
Nature Immunology|February 19, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cellsYetao Wang, Lawrence Lifshitz, Kyle Gellatly, et al.
JCI Insight|June 30, 2026
A distinct form of fat fibrosis is linked to insulin resistance in people with HIVDiana L Alba, Alaa Abdellatif, Moon K Choi, et al.
Journal of Virology|May 8, 2020
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M SubtypesGisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, et al.
Pageof 35

Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
A Distinct Form of Subcutaneous Fat Fibrosis Predicts Insulin Resistance in People with HIVDiana L Alba, Moon K Choi, Alaa Abdellatif, et al.
The Journal of Infectious Diseases|September 9, 2015
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral TherapyMark J Siedner, June-Ho Kim, Ruth Sentongo Nakku, et al.
Blood|April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialPeter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
Cannabis and Cannabinoid Research|March 26, 2026
Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIVStephanie A Ruderman, Joseph A C Delaney, Kristina A Crothers, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
AIDS (London, England)|February 26, 2021
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in UgandaSuzanne M McCluskey, Kimia Kamelian, Nicholas Musinguzi, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
Nature Immunology|February 19, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cellsYetao Wang, Lawrence Lifshitz, Kyle Gellatly, et al.
JCI Insight|June 30, 2026
A distinct form of fat fibrosis is linked to insulin resistance in people with HIVDiana L Alba, Alaa Abdellatif, Moon K Choi, et al.
Journal of Virology|May 8, 2020
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M SubtypesGisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, et al.
Pageof 35